Oculus Innovative Sciences Announces Fiscal Third Quarter 2014 Financial Results and Conference Call

Oculus Innovative Sciences Announces Fiscal Third Quarter 2014 Financial
Results and Conference Call

PETALUMA, Calif., Jan. 30, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative
Sciences, Inc. (Nasdaq:OCLS) today announced that the financial results for
its fiscal third quarter 2014, ended December 31, 2013, will be released after
the U.S. market closes on February 13, 2014. The earnings release will be
followed by a conference call at 1:30 p.m. PT (4:30 p.m. ET) on February 13,
2014, to discuss fiscal third quarter results.

Individuals interested in participating in the conference call may do so by
dialing 877-303-7607 for domestic callers or 973-638-3203 for international
callers. Those interested in listening to the conference call live via the
Internet may do so at http://ir.oculusis.com/events.cfm. Please log on
approximately 30 minutes prior to the presentation in order to register and
download the appropriate software.

A telephone replay will be available for seven days following the conclusion
of the call by dialing 855-859-2056 for domestic callers, or 404-537-3406 for
international callers, and entering conference code 51346784. A webcast replay
will be available on the site at http://ir.oculusis.com/events.cfm for one
year following the call.

About Oculus Innovative Sciences

Oculus Innovative Science is a global healthcare company that designs,
manufactures and markets prescription and non-prescription products in 31
countries. The company's products are used to treat patients in
surgical/advanced wound management, dermatology, women's health and animal
health; addressing the unmet medical needs of these markets, while raising the
standard ofpatient care and lowering overall healthcare costs. The company's
headquarters are in Petaluma, California, with manufacturing operations in the
United States and Latin America. More information can be found
atwww.oculusis.com.

CONTACT: Media and Investor Contact:
         Oculus Innovative Sciences, Inc.
         Dan McFadden
         VP of Public and Investor Relations
         (425) 753-2105
         dmcfadden@oculusis.com